Chinook Therapeutics

Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.

Industries

Biotechnology

Headquarters

Vancouver, Canada

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Eric Dobmeier

President & CEO

Collapse

Tom Frohlich

Chief Operating Officer

Eric Bjerkholt

Chief Financial Officer

Andrew King

Chief Scientific Officer

Andrew Oxtoby

Chief Commercial Officer

Kirk Schumacher

SVP & General Counsel

Delphine Imbert

SVP, CMC & Technical Operations

Charlotte Jones-Burton

SVP, Product Development & Strategy

Jodi Jamieson

SVP, Human Resources

Noopur Liffick

SVP, Investor Relations & Corporate Communications

Valerie Fauvelle

SVP, Regulatory Affairs

Teams

View all

Leadership Team

7 members

CEO and Executive Team

6 members

Board of Directors

6 members

Discover similar companies

Geneseeq Technology

Toronto, Canada · Series D

Cytodyn

Vancouver, United States · Post IPO Equity

Zymeworks

Vancouver, Canada · Post IPO Equity

Triumvira Immunologics

Hamilton, Canada · Series A

Verve Therapeutics

Cambridge, United States · IPO

Helix

San Mateo, United States · Series C

Guardant Health

Redwood City, United States · Venture

Callitas Therapeutics

Vancouver, Canada

AbCellera

Vancouver, Canada

Scipher Medicine

Waltham, United States · Series D

Natera

Austin, United States · Post IPO Equity

Genevant Sciences

Vancouver, Canada

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.